Cell Culture
LAB COMPANION
YOUR BENCH WORKSPACE

MCF7: reference & planning

Compare source conditions and connect them to a measured preparation plan.

No account required
Cell-line reference

MCF7 HTB-22

Sourced reference

Vendor conditions describe the referenced product and formulation. Match these to your lab’s approved protocol and culture history.

View source · ATCC
Reviewed 2026-09-28
Media calculation needs your lab-confirmed insulin target. Remaining handling fields are not yet verified.

Culture environment

37°C · 5% CO₂ in air
Adherent and/or suspension · Human · Breast

Medium

ATCC-formulated EMEM
10% FBS (final v/v)

Human recombinant insulin: The current ATCC entry lists 1.4 mL of a 4 mg/mL insulin stock without an explicit final batch volume in that instruction. A scalable target concentration has not been verified. Enter the target from your lab protocol.

Passaging

ATCC gives a reference split range of 1:3–1:6, or 4 × 10⁴–1 × 10⁵ viable cells/cm².

Reference data not yet verified.

Growth

Reference data not yet verified.

Cryopreservation

ATCC lists complete growth medium with 5% v/v DMSO.

View source · ATCC
Reviewed 2026-09-28

From reference to calculation

MCF7: resolve the insulin denominator before scaling a recipe

A supplement stock volume is not a final concentration. The missing final batch volume matters even when the stock strength is known.

Scientific contributor: Dr. Tayner Rodriguez Garzon · Published by Cell Culture Tools · How content is prepared

Published 2 November 2026 · Illustrative calculations; use your approved protocol for biological conditions.

What is known, and what is still needed

The ATCC HTB-22 entry identifies EMEM, 10% FBS and a 1.4 mL addition of a 4 mg/mL recombinant insulin stock. The retrieved supplement instruction does not explicitly identify the final batch volume associated with that addition. The site therefore leaves the scalable insulin target for your lab to confirm.

The stock addition contains 1.4 × 4 = 5.6 mg insulin. To obtain a final concentration, divide that mass by the completed volume. Assuming a bottle size silently would turn an incomplete instruction into an apparently precise target.

Worked comparison: the same mass in two hypothetical volumes

The following denominators are deliberately hypothetical. Neither row is a recommended MCF7 formulation, and neither resolves the missing information in the supplier instruction.

Why a final batch volume is essential
Insulin massHypothetical final volumeCalculated concentration
5.6 mg250 mL0.0224 mg/mL = 22.4 µg/mL
5.6 mg500 mL0.0112 mg/mL = 11.2 µg/mL

Once a target is confirmed, use matching units

The media calculator uses V(stock) = C(target) × V(final) ÷ C(stock). For a separate arithmetic example, a lab-confirmed target of 0.008 mg/mL in 250 mL with a 4 mg/mL stock would require 0.5 mL stock. The example target is invented solely to demonstrate the calculation.

At 10% FBS, the same illustrative final batch would contain 25 mL FBS, 0.5 mL insulin stock and 224.5 mL basal medium if there are no other additions. The stock volume counts towards the final volume. Adding these supplements to an existing 250 mL of basal medium would give a different final concentration.

Separate a count from an appearance-based estimate

The ATCC record describes loosely attached clusters and floating viable cells during recovery. A count of only one collected fraction is not automatically the viable count of the entire culture. Record what was included in the counted suspension and use the supplier’s full handling procedure for recovery decisions.

Use measured viable cells for a quantitative seeding plan whenever those are the inputs required by your protocol. The app does not supply a universal conversion between an MCF7 image, a confluence percentage and viable cells. An unknown growth parameter remains unknown rather than being copied from another breast-cancer line.

Sources and the next calculation

ATCC HTB-22: MCF7 product information supports the stated product context. The interpretation above was prepared using product information retrieved on 1 November 2026; the reference cards retain their own field-review dates. The worked comparisons are original arithmetic examples, not reported experimental results.

Spot an unclear assumption? Send the page, input values and source for a correction.